(Bloomberg) -- Banks and other lenders are lining up more than €10 billion ($11.1 billion) of debt to back a buyout of Sanofi SA’s consumer health division, as one of the most hotly-anticipated sales of the year reaches its final stages.

Most Read from Bloomberg

• Unlocking the Hidden Power of Zoning, for Good or Bad

• The Moonshot Plan to Eliminate Deaths on America’s Roads

• Belfast’s Grand Central Station Creates New Era for Northern Ireland’s Public Transport

• Eric Adams' Vanishing Promise to Fix NYC's 'Unfair' Property Taxes

A core group of banks signed funding commitments over the weekend for €7.5 billion to €7.8 billion of senior debt to back bids for the acquisition, people familiar with the matter said, declining to be identified discussing private matters. They will also give around €1.2 billion of revolving credit facility.

Private credit lenders are also lining up around €1.5 billion to €2 billion of junior debt to fund the buyout.

New York-based buyout firm Clayton Dubilier & Rice is competing with French rival PAI Partners for Sanofi’s unit, with bids due this month. The former is being advised by Citigroup Inc. and the latter by JPMorgan Chase & Co., two of the people said. The debt packages backing CD&R and PAI’s bids are fairly similar, and include a mix of euro and dollar-denominated leveraged loans and high yield bonds to attract as much liquidity from institutional investors as possible, they added.

While Sanofi didn’t comment on the financing, a representative reiterated that the firm is considering potential separation scenarios for the consumer business, including a sale or a stock market listing, with a decision likely in the next few months. Spokespeople for CD&R, PAI, JPMorgan and Citi declined to comment.

Banks are eager to return to funding leveraged buyouts, with as many as 15 jostling for the financing on the Sanofi bids. Such deals are some of the most lucrative operations in finance, particularly after the first Federal Reserve interest rate cut in four years raised hopes that debt costs are finally starting to ease.

But the risks are still fresh on many people’s memories: Just two years ago, lenders got burned backing big corporate buyouts and ended up with tens of billions of dollars of “hung debt” they struggled to get rid of.

The total leverage provided by banks will likely be six times the unit’s earnings, a level that’s fairly high by recent standards. That figure rises to 7.5 times once the private credit element is factored in. Just over a year ago, the debt packages lined up by banks to back buyouts were around four times earnings.

Bloomberg News previously reported that New York-based buyout firm CD&R is also in discussions with banks to provide back leverage to fund part of the equity check. Back leverage is a type of loan that buyout shops can obtain to finance part of an equity investment in a specific company.

Most Read from Bloomberg Businessweek

• Palantir’s CEO and Wall Street Annoy Each Other Straight to the Bank

• Five Reasons to Be Optimistic About the Entertainment Business

• The Man Who Made Nike Uncool

• In Yosemite, Problems With Concessions Keep Piling Up

• Threats to Local US Election Officials Are Rising, and More Workers Are Quitting

©2024 Bloomberg L.P.